Patient description: The patient is a 14-year-old boy complaining of scoliosis and back pain. He has no other medical condition. He used to be able to play routine activities such as basketball and soccer, however, he recently has problem doing them. The pain is in his leg and back and aggravated by physical activities. He prefer lying down most of the time. He is not happy with his body gesture and complaints of shoulder imbalance and shifting his head to right. Patient is a well-dressed and well-nourished adolescent who is alert and cooperative. The left shoulder is slightly higher than the right shoulder. The scoliotic curve is measured as 45 degree. The patients is candidate for scoliosis surgery according to perioperative MEP monitoring

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Chronic Low-Back Pain Refractory Pain Neuropathic Pain Patient must be willing and able to provide written informed consent prior to any clinical investigation-related procedure. 2. Age ≥ 18 years 3. Patient has chronic (at least 6 months), refractory axial low back pain with a neuropathic component and is not a candidate for spine surgery 4. Patient has back pain for ≥ 6 months inadequately responsive to supervised conservative care 5. Patient has not had spine surgery for back or leg pain 6. Patient is a candidate for spinal cord stimulation 7. Low back pain ≥ 6 on Numerical Rating Scale 8. Oswestry Disability Index score of ≥ 30% 9. Willing and able to comply with the instructions for use, operate the study device, and comply with this Clinical Investigation Plan  Pathology seen on imaging tests obtained within the past 12 months that is clearly identified and is likely the cause of the CLBP, that can be addressed with surgery. 2. Primary complaint of leg pain, or leg pain is greater than back pain 3. Back pain is due to any of the following spinal instability defined as > 2 mm translation on radiographic imaging visceral causes (e.g., endometriosis or fibroids) vascular causes (e.g., aortic aneurysm) spinal infection (e.g., osteomyelitis) inflammation or damage to the spinal cord (e.g. arachnoiditis or syringomyelia) tumor or spinal metastases 4. Has widespread pain (e.g. fibromyalgia) or pain in other area(s), not intended to be treated in this study (e.g. neck pain, shoulder pain) 5. Patient has seronegative spondyloarthropathy (e.g. rheumatoid, lupus, psoriatic) 6. Neurological deficit (e.g. foot drop) 7. Prior lumbar spine surgery or sacroiliac joint fusion 8. Patient has used a morphine equivalent daily dose of more than 50 MME in the last 30 days 9. Patient is bed bound 10. Patients with regular intake of systemic steroids (except inhaled steroids used to treat asthma) 11. Imaging (MRI, CT, X-ray) findings within the last 12 months that contraindicates lead placement 12. Known allergic reaction to implanted materials 13. Severe scoliotic deformity (>11 degrees in thoracic or lumbar spine) 14. Patient has a history of, or existing intrathecal drug pump 15. Patient has previous experience with neuromodulation devices, including a failed trial 16. BMI > 40 17. Patient is enrolled, or intends to participate, in another clinical drug and/or device study or registry that may interfere with the results of this study, as determined by Abbott personnel 18. Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements of the clinical investigation results. 19. Failed psychological evaluation 20. Suspicion or evidence of untreated mental illness, or substance abuse 21. Patient demonstrated 2 or more Waddell's signs of nonorganic behavior 22. Patient is in current litigation for back pain/injury, or is currently receiving worker's compensation 23. Pregnant or nursing subjects and those who plan pregnancy during the clinical investigation follow-up period Female subjects of child-bearing potential must have a negative pregnancy test done within 7 days prior to enrollment/baseline visit per site standard test